These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28592602)

  • 1. Cholecystokinin responsiveness varies across the population dependent on metabolic phenotype.
    Desai AJ; Dong M; Langlais BT; Dueck AC; Miller LJ
    Am J Clin Nutr; 2017 Aug; 106(2):447-456. PubMed ID: 28592602
    [No Abstract]   [Full Text] [Related]  

  • 2. Screening for positive allosteric modulators of cholecystokinin type 1 receptor potentially useful for management of obesity.
    Dengler DG; Sun Q; Harikumar KG; Miller LJ; Sergienko EA
    SLAS Discov; 2022 Oct; 27(7):384-394. PubMed ID: 35850480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
    Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
    Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a Positive Allosteric Modulator of Cholecystokinin Action at CCK1R in Normal and Elevated Cholesterol.
    Harikumar KG; Coudrat T; Desai AJ; Dong M; Dengler DG; Furness SGB; Christopoulos A; Wootten D; Sergienko EA; Sexton PM; Miller LJ
    Front Endocrinol (Lausanne); 2021; 12():789957. PubMed ID: 34950108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic Actions of the Type 1 Cholecystokinin Receptor: Its Potential as a Therapeutic Target.
    Miller LJ; Desai AJ
    Trends Endocrinol Metab; 2016 Sep; 27(9):609-619. PubMed ID: 27156041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensing of L-Arginine by Gut-Expressed Calcium Sensing Receptor Stimulates Gut Satiety Hormones Cholecystokinin and Glucose-Dependent Insulinotropic Peptide Secretion in Pig Model.
    Wang C; Kang C; Xian Y; Zhang M; Chen X; Pei M; Zhu W; Hang S
    J Food Sci; 2018 Sep; 83(9):2394-2401. PubMed ID: 30088839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of Cholecystokinin in the Nutritional Continuum. Physiology and Potential Therapeutics.
    Miller LJ; Harikumar KG; Wootten D; Sexton PM
    Front Endocrinol (Lausanne); 2021; 12():684656. PubMed ID: 34149622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leptin resistance in vagal afferent neurons inhibits cholecystokinin signaling and satiation in diet induced obese rats.
    de Lartigue G; Barbier de la Serre C; Espero E; Lee J; Raybould HE
    PLoS One; 2012; 7(3):e32967. PubMed ID: 22412960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intracellular interplay between cholecystokinin and leptin signalling for satiety control in rats.
    Koizumi H; Mohammad S; Ozaki T; Muto K; Matsuba N; Kim J; Pan W; Morioka E; Mochizuki T; Ikeda M
    Sci Rep; 2020 Jul; 10(1):12000. PubMed ID: 32686770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic, pharmacological and functional analysis of cholecystokinin-1 and cholecystokinin-2 receptor polymorphism in type 2 diabetes and obese patients.
    Marchal-Victorion S; Vionnet N; Escrieut C; Dematos F; Dina C; Dufresne M; Vaysse N; Pradayrol L; Froguel P; Fourmy D
    Pharmacogenetics; 2002 Jan; 12(1):23-30. PubMed ID: 11773861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholecystokinin and satiety: current perspectives.
    Moran TH
    Nutrition; 2000 Oct; 16(10):858-65. PubMed ID: 11054590
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraperitoneal CCK and fourth-intraventricular Apo AIV require both peripheral and NTS CCK1R to reduce food intake in male rats.
    Lo CC; Davidson WS; Hibbard SK; Georgievsky M; Lee A; Tso P; Woods SC
    Endocrinology; 2014 May; 155(5):1700-7. PubMed ID: 24564397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Benefits of Sustained Upregulated Unimolecular GLP-1 and CCK Receptor Signalling in Obesity-Diabetes.
    Tanday N; English A; Lafferty RA; Flatt PR; Irwin N
    Front Endocrinol (Lausanne); 2021; 12():674704. PubMed ID: 34054734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of β-sitosterol on type 1 cholecystokinin receptor dysfunction induced by elevated membrane cholesterol.
    Desai AJ; Dong M; Miller LJ
    Clin Nutr; 2016 Dec; 35(6):1374-1379. PubMed ID: 27016394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of independent and combined metabolic effects of chronic treatment with (pGlu-Gln)-CCK-8 and long-acting GLP-1 and GIP mimetics in high fat-fed mice.
    Irwin N; Hunter K; Montgomery IA; Flatt PR
    Diabetes Obes Metab; 2013 Jul; 15(7):650-9. PubMed ID: 23388064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of vagal afferent excitation and reduction of food intake by leptin and cholecystokinin.
    Peters JH; Simasko SM; Ritter RC
    Physiol Behav; 2006 Nov; 89(4):477-85. PubMed ID: 16872644
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cimetidine reduces weight and improves metabolic control in overweight patients with type 2 diabetes.
    Støa-Birketvedt G; Paus PN; Ganss R; Ingebretsen OC; Florholmen J
    Int J Obes Relat Metab Disord; 1998 Nov; 22(11):1041-5. PubMed ID: 9822940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved glycemic control increases fasting plasma acylation-stimulating protein and decreases leptin concentrations in type II diabetic subjects.
    Ozata M; Gungor D; Turan M; Ozisik G; Bingol N; Ozgurtas T; Ozdemir IC
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3659-64. PubMed ID: 11502793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin.
    Dockray GJ
    Curr Opin Endocrinol Diabetes Obes; 2012 Feb; 19(1):8-12. PubMed ID: 22157397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacological therapy of obesity].
    Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.